Fiona Sellwood

Fiona Sellwood is a highly experienced regulatory affairs professional with a robust background in the pharmaceutical industry. Currently serving as the Global Head of Regulatory Affairs and Head of Regulatory Strategy and Portfolio Development at Allergy Therapeutics since August 2018, Fiona previously held significant roles including Head of Regulatory Strategy for Pain at Mundipharma Research. Prior experience includes Vice President of Global Regulatory Affairs at Glenmark Pharmaceuticals, where Fiona led innovative product regulatory development, and regulatory consulting roles at Biogen Idec and Pharmalink Consulting. Early career positions include Head of Regulatory Affairs at Pfizer and Parke Davis. Fiona has a proven track record in managing regulatory strategies for new chemical entities, biologics, and biosimilars across various therapeutic areas.